OraQuick Accuracy at Day 60 Post-Exposure
The OraQuick oral HIV self-test at 60 days post-exposure is insufficient for definitively ruling out HIV infection and should not be used as the sole test at this timepoint.
Key Performance Limitations
The OraQuick oral fluid test has inherent limitations that make it inadequate for post-exposure testing at 60 days:
Sensitivity Issues
- General sensitivity: Studies show OraQuick oral fluid tests achieve 98.7-99.5% sensitivity compared to blood-based tests in standard populations 1, 2, 3
- Critical gap in acute infection: Oral fluid tests are less sensitive for detecting acute or recent infection than blood tests 4
- Delayed seroconversion: The oral fluid test has a longer window period than blood-based antigen/antibody tests, meaning it takes longer to detect new infections
Impact of Antiretroviral Exposure
If the exposed person took post-exposure prophylaxis (PEP), this creates additional problems:
- ARVs suppress HIV viral load and delay seroconversion, decreasing the ability to detect HIV infection 4
- In one study, participants receiving tenofovir took 191.8 days to develop a reactive OraQuick compared to only 16.8 days for those not on antiretrovirals 5
- This means OraQuick at day 60 could easily miss an infection in someone who took PEP
Recommended Testing at Day 60
Current CDC guidelines (2025) specify that at 60 days post-exposure (approximately 4-6 weeks after starting PEP), testing should include BOTH 4:
- Laboratory-based HIV antigen/antibody (Ag/Ab) combination test
- Diagnostic HIV nucleic acid test (NAT)
This dual approach is necessary because:
- The Ag/Ab test detects both HIV antibodies and p24 antigen, providing earlier detection than antibody-only tests
- The NAT detects HIV RNA directly, identifying infection approximately 1 week before even the Ag/Ab test 4
- Together, they maximize sensitivity during the period when ARVs may be suppressing viral markers
Final Testing Timeline
The definitive test to rule out HIV infection after exposure requires waiting until 12 weeks (84 days) post-exposure, using both laboratory-based Ag/Ab test and diagnostic NAT 4. This 12-week timepoint accounts for:
- ARV washout period after completing PEP
- Window period of the HIV tests themselves
- Time needed for seroconversion in delayed cases
Clinical Bottom Line
Do not rely on OraQuick oral fluid testing at day 60 post-exposure. The combination of:
- Inherently lower sensitivity for acute infection
- Longer window period than blood tests
- Potential suppression from PEP medications
- Oral fluid specimen type (less sensitive than blood)
...makes this approach inadequate for post-exposure follow-up. Use laboratory-based blood testing with both Ag/Ab and NAT at 4-6 weeks, and repeat at 12 weeks for definitive exclusion of HIV infection 4.